Can Sarısözen

Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors

Erem Bilensoy, Can Sarısözen, Güneş Esendağlı et al. · International Journal of Pharmaceutics · 2008 · 160 citations

Cell-based Drug Delivery, Nanomedicine, Intravesical Cationic Nanoparticles +6

The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors

Can Sarısözen, Abraham H. Abouzeid, Vladimir P. Torchilin · European Journal of Pharmaceutics and Biopharmaceutics · 2014 · 145 citations · Full text

Nanomedicine, Resistant Ovarian Cancer, Drug Targeting +11

Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid

Shravan Kumar Sriraman, G. Salzano, Can Sarısözen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2016 · 112 citations

Nanomedicine, Medicinal Chemistry, Nanotherapeutics +9

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?

Cemil Bilir, Can Sarısözen · Journal of Oncological Sciences · 2017 · 108 citations · Full text

Reductive Stress, Ido Functions, Aldehyde Dehydrogenase +15

Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models

Can Sarısözen, Shekhar Dhokai, Edcar G. Tsikudo et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2016 · 104 citations

Nanoparticles, Nanomedicine, Neuro-oncology +12